Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Fund

Trinity Capital Inc. (TRIN)

An internally managed BDC providing secured term loans, equipment financings, and select equity and warrants to growth-stage companies.

Fund website ↗
Structureventure debt BDC
ExchangeNASDAQ
NAV / share$13.27Mar 31, 2026 · source ↗
Market price$17.78Jul 17, 2026 · source ↗
Premium / discount+34.0%Derived from latest NAV and price
Net assets$1.2BMar 31, 2026 · source ↗

Latest observation

NAV vs. market price

Reported dates shown below.

NAV / share$13.27Mar 31, 2026 · source ↗
Market price$17.78Jul 17, 2026 · source ↗

Fund facts

Manager
Trinity Capital Inc. (internally managed)
NAV frequency
quarterly
Primary filing
10-Q
Expense ratio
—

Schedule of investments

Debt investments

Mar 31, 2026 reporting period

CompanySecurity typePrincipalCostFair valueFV / principalRateMaturityNon-accrual
Uniphore TechnologiesAI & automationsenior secured loan$49.5MMar 31, 2026 · source ↗—Mar 31, 2026 · source ↗$48.3MMar 31, 2026 · source ↗97.6%Mar 31, 2026 · source ↗P+4.8% (12.3% floor, 3.0% EOT)Mar 31, 2026 · source ↗Oct 1, 2030Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗
Candel TherapeuticsBiotechnologysenior secured loan$43.5MMar 31, 2026 · source ↗—Mar 31, 2026 · source ↗$42.5MMar 31, 2026 · source ↗97.8%Mar 31, 2026 · source ↗P+3.0% (9.8% floor, 4.3% EOT)Mar 31, 2026 · source ↗Oct 1, 2030Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗
iGrafxAI & automationsenior secured loan$24.9MMar 31, 2026 · source ↗—Mar 31, 2026 · source ↗$24.9MMar 31, 2026 · source ↗99.9%Mar 31, 2026 · source ↗1M SOFR+5.8% (0.0% EOT)Mar 31, 2026 · source ↗Nov 12, 2028Mar 31, 2026 · source ↗NoMar 31, 2026 · source ↗

Schedule of investments

Warrant & equity positions

Mar 31, 2026 reporting period

CompanyFair value% of NAVSecurityImplied price / shareMethodology / source

Position history

Reported fair-value marks

Each bar is a disclosed position-quarter.

$48.3MUniphore TechnologiesMar 31, 2026 · source ↗$42.5MCandel TherapeuticsMar 31, 2026 · source ↗$24.9MiGrafxMar 31, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation